Olink

Olink®
Part of Thermo Fisher Scientific

Webinars

Discover innovation and expertise with our webinar series. Choose from three formats: Product Insights (learn about Olink’s products in depth), Application Focus (see how customers use Olink technology to advance their research), and Technical Proficiency (hosted by our expert support team with practical tips and strategies).

Filters

WebinarApplicationTypeProducts

Beyond Genomics: A Conversation with Thought Leaders on NGS-Based Proteomics

Join our conversation with global thought leaders as they unpack the latest trends, breakthroughs, and future directions in NGS-based proteomics.

Products

Technical Webinar: Unlock the full potential of your research with Olink’s bridging normalization

Join our technical experts for a deep dive into normalization strategies, showcase real-world examples, and offer practical solutions to maximize the power of your studies.

Products

Uncovering Proteomic Biomarkers Linking Type 2 Diabetes to Cardiovascular Risk

Cardiovascular expert Prof. Karol Kaminski, MD, PhD, presents a study that identified proteomic biomarkers in individuals with untreated glucose metabolism disturbances who are not diagnosed with diabetes, chronic inflammatory, neoplastic, or cardiovascular disease.

Products

Advancing Precision Medicine in Inflammatory Diseases with Affinity-Based Proteomics

Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting joints, entheses, and skin, and is linked to higher risks of cardiovascular disease and MASLD. These associations reflect complex inflammation-metabolism interactions, but treatment effects remain unclear.

Products

A Complete Solution for Identifying Protein Signatures: From Sample to Actionable Results

Explore how the Olink® Signature Q100 benchtop system and NPX Signature software are part of a complete solution for generating meaningful protein signatures, from study design to data interpretation.

Products

The Proteomics Frontier Webinar Series: Transforming Neurology and Driving Precision Medicine

Dive into the transformative power of Olink's proteomics platform and its revolutionary impact on neurological research and precision medicine. Learn how large-scale protein studies are unlocking the secrets of neurological disorders and revolutionizing medicine.

Products

Technical Webinar: Study design considerations when running alternative matrices

Join our technical experts for a deep dive into study design considerations for Olink projects using alternative matrices.

Products

Using NGS-Based Proteomics to Differentiate BTK Inhibitor Response in Leukemia

This webinar will highlight a study that compares the effect of three different BTK inhibitors: ibrutinib, acalabrutinib, and zanubrutinib. Patient samples were obtained before and at various time points after treatment to identify biomarkers that could be informative of the treatment’s effects.

Products

Immune-competent vascularized human cerebral organoids to study brain development and disease: a multiomics approach

The Network Biology Collaborative Centre at Mount Sinai Hospital, an Olink Certified Service Provider, present their application of Olink’s Proximity Extension Assay technology to profile an organoid-based model that provides novel regulatory and mechanistic insights into human brain development.

Products

Advancing proteomics in clinical research with the combined strengths of mass spectrometry and affinity-based methods

A roundtable discussion between key opinion leaders in proteomics explores how integrating antibody-based methods, like proximity extension assay (PEA), with LC-MS can expand proteome coverage, facilitate biomarker discovery, and streamline the validation process.

Products

Charting the Future of Mental Health Precision Medicine with Proteomics

Results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD) using Olink Explore HT. This research investigated a cohort of 50 mothers diagnosed with PPD, focusing on discovering proteins that may serve as unique biomarkers for early detection and treatment.

Products

Affinity Proteomics and LC-MS synergize Biomarker Discovery

Olink Certified Service Provider, Discovery Life Sciences, compares cutting-edge technology to study the proteome in liquid matrices.

Products

Integrating plasma proteomics to identify tuberculosis-specific diagnostic biomarkers

Using mass spectrometry, Olink’s proximity extension assay, cross-disciplinary research, and international collaboration, Dr. Schiff and team have identified protein biomarkers with high TB-specificity and demonstrated the diagnostic performance of a six-protein diagnostic panel.

Products

Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics

Anders Mälarstig, Director of Target Sciences at Pfizer, presents the integration of multi-omics for cancer prevention, large-scale proteomics analyses, and the use of high-throughput proteomics to identify actionable biomarkers for improved cancer diagnosis and treatment.

Products

What is a Good Biomarker?

Olink experts review the critical role of protein biomarkers in advancing personalized medicine, the challenges and opportunities of the protein biomarker development pipeline, and how PEA is facilitating the journey from discovery to clinical utility while delivering reproducible insights.

Products

Maternal inflammation during pregnancy and risk of immune-mediated diseases in birth cohorts

Jonathan Thorsen, MD Ph.D., Senior Researcher at COPSAC, presents a webinar on the HEDIMED project, which analyzed perinatal blood samples from four northern European birth cohorts to identify immune markers for childhood diseases, using the Olink Target96 Inflammation platform.

Products

Circulating inflammatory biomarkers associated with cognitive function and dementia

Dr. Margaret Doyle examines inflammation's role in cognitive decline and Alzheimer's using Olink proteomics, identifying key inflammatory biomarkers and their associations with cognitive domains in the Framingham Heart Study.

Products

Detecting Cancer Biomarkers from Proteins in Liquid Biopsies

Join Klaus Pantel, Chairman and Founding Director, Institute for Tumor Biology, and Christoffer Gebhardt, Head, university Skin Cancer Center, Hamburg, as they discuss the role of circulating protein biomarkers, technological advancements, and clinical applications in implementing liquid biopsy.

Products

The right drug targets for the right patient – Using biomarkers to solve challenges in drug development

Dr. Jürgen Braunger of Boehringer Ingelheim Pharma, Dr. Timothy Radstake of AbbVie and Dr. Christopher D. Whelan of Biogen discuss clinical trials, current practices, historical context, and future challenges. Learn how protein markers enhance patient stratification by disease severity.

Products

Identification of predictive biomarkers of immunotherapy efficacy in cancer patients through analysis of plasma proteomics

Professor Antoine Italiano (Head of Early Phase Trials and Sarcoma Unit, Institut Bergonié) presents how protein biomarkers are providing an improve understanding and characterization of cancer patients stratification within Immuno-Oncology.

Products

30 webinars